Replies to post #562237 on NorthWest Biotherapeutics Inc (NWBO)

[Dr Bala]

Irrelevant nonsense after the recent successes in results and publication in a top tier journal.

[dstock07734]

Delusional nonsense.

[CrashOverride]

Did you make that offer, Adam?

[learningcurve2020]

LOL. Another mic drop by Ex. But it doesn't matter.

It's like NWBO is the Twilight Zone of biotech, existing in another dimension.

>>The current standard of care, surgical resection followed by concurrent administration of radiation and temozolomide (Temodar), has remained unchanged for almost 2 decades.2,3 The FDA has not approved a drug for GBM since temozolomide, and no novel agents have been shown to prolong patient survival.

https://www.onclive.com/view/a-new-take-on-preclinical-drug-trials-for-gbm-treatment

>>A randomized phase III trial in newly diagnosed GB patients found that (DCVax®-L) conferred longer OS in all patients, especially in those with MGMT methylation. However, crossover had led to 90% of the patients receiving the vaccine, making it difficult to draw definite conclusions.122 In a recent report the 64 patients with recurrent WBC who crossed over to DCVAX treatment had an mOS of 13.2 (95% CI, 9.7–16.8) months from relapse vs 7.8 (95% CI, 7.2–8.2) months among control patients (HR, 0.58; 98% CI, 0.00–0.76; P < 0.001).123 Methodological problems in the study design obscure these results.124

https://www.dovepress.com/recurrent-glioblastoma-ongoing-clinical-challenges-and-future-prospect-peer-reviewed-fulltext-article-OTT